Featured Research

from universities, journals, and other organizations

Post-transplant patients off steroids have fewer cardiovascular events, study finds

Date:
May 7, 2010
Source:
University of Cincinnati Academic Health Center
Summary:
Post-transplant patients who have been removed from a corticosteroid regimen have fewer cardiovascular events than those patients on steroids, increasing their graft survival rates and reducing early mortality, according to a study by transplantation researchers.

Plasma cell.
Credit: Courtesy of the UC transplant division.

Post-transplant patients who have been removed from a corticosteroid regimen have fewer cardiovascular events than those patients on steroids, increasing their graft survival rates and reducing early mortality, according to study results being presented by University of Cincinnati (UC) transplantation researchers.

Related Articles


Researchers with the division of transplantation and department of internal medicine are presenting the work at the American Transplant Congress (ATC), the annual meeting of the American Society of Transplantation, held May 1-5 in San Diego.

Corticosteroids are commonly given to post-transplant patients as part of an immunosuppressive regime to promote graft survival. But the steroids also cause harmful cardiovascular side effects such as increased blood pressure, cholesterol and weight gain, says Rita Alloway, PharmD, UC research professor of internal medicine. UC's transplant clinical research team has largely focused on reducing patient exposure to corticosteroids during post-transplantation treatment.

"Ten years ago, almost 80 percent of post-transplant kidney patients were discharged from the hospital on steroids," she says. "Now, according to United Network for Organ Sharing (UNOS) reports, less than 20 percent are discharged from the hospital on steroids. We've effectively removed chronic steroids from the immunosuppressive regimen while maintaining similar graft survival outcomes."

In work led by UC research assistant professor of surgery Adele Rike Shields, PharmD, researchers are now able to show patients removed from a steroid treatment have decreased cardiovascular events after transplant, in addition to their lowered side effects.

Shields evaluated acute graft rejection and graft loss in 630 kidney transplant patients withdrawn from corticosteroids. She found the risk factors in the corticosteroid-withdrawn kidney transplant population are similar to those traditionally defined under conventional immunosuppression with steroids.

"With the summation of 10 years of work, we've been able to show that patients off corticosteroids have the same graft-function outcomes as patients on corticosteroids," says Alloway. "In addition, the patients off corticosteroids benefit from fewer cardiovascular events."

UC researchers are also presenting the results of continued studies on use of the cancer drug bortezomib in solid organ transplant recipients. Altogether, 10 abstracts on UC-led bortezomib work will be featured at the meeting.

In a study published in the December 2008 issue of Transplantation, UC director of transplantation E. Steve Woodle, MD, and his colleagues showed bortezomib, a cancer drug commonly used to treat cancer of the plasma cells, is effective in treating rejection episodes caused by antibodies that attack transplanted kidneys.

Now, says Alloway, UC is presenting data from the next logical series of studies on the drug's use in transplantation, including its effect on both late and early acute rejection and the desensitization of patients with high antibody levels pre-transplant.

In work presented by transplant pharmacy fellow Carlin Walsh, PharmD, investigators demonstrated the ability of bortezomib to significantly reduce the level of donor-specific antibodies when prior therapies have failed. Walsh received a Young Investigator Award from the American Society of Transplantation for the desensitization studies with bortezomib.

UC researchers are also reporting results of shared protocols on the bortezomib treatment for antibody-mediated rejection. After presenting their bortezomib findings at the 2009 ATC, UC researchers created the START collaborative to share standard of care treatment protocols for bortezomib therapies. Through the collaborative, transplant centers worldwide have requested this information to treat individual patients with a variety of solid organ transplant types.

"The information shared from this partnership represents an international collaborative experience of treating this unmet need in transplantation that inevitably results in graft loss," says Alloway. "Because transplant centers may have one to five antibody-mediated cases a year, it's difficult to assess a potential new treatment. But when you are able to share every center's cases together in one report, it's easier to identify trends that support definitive design of future controlled trials."


Story Source:

The above story is based on materials provided by University of Cincinnati Academic Health Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Cincinnati Academic Health Center. "Post-transplant patients off steroids have fewer cardiovascular events, study finds." ScienceDaily. ScienceDaily, 7 May 2010. <www.sciencedaily.com/releases/2010/05/100507121252.htm>.
University of Cincinnati Academic Health Center. (2010, May 7). Post-transplant patients off steroids have fewer cardiovascular events, study finds. ScienceDaily. Retrieved April 25, 2015 from www.sciencedaily.com/releases/2010/05/100507121252.htm
University of Cincinnati Academic Health Center. "Post-transplant patients off steroids have fewer cardiovascular events, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/05/100507121252.htm (accessed April 25, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, April 25, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

85 Killed in Niger by Meningitis Since Start of Year

85 Killed in Niger by Meningitis Since Start of Year

AFP (Apr. 24, 2015) A meningitis outbreak in Niger has killed 85 people since the start of the year prompting authorities to close schools in the capital Niamey until Monday. Video provided by AFP
Powered by NewsLook.com
C-Section Births a Trend in Brazil

C-Section Births a Trend in Brazil

AFP (Apr. 24, 2015) More than half of Brazil&apos;s babies are born via cesarean section, as mothers and doctors opt for a faster and less painful experience despite the health risks. Duration: 02:02 Video provided by AFP
Powered by NewsLook.com
Anti-Malaria Jab Hope

Anti-Malaria Jab Hope

Reuters - News Video Online (Apr. 24, 2015) The world&apos;s first anti-malaria vaccine could get the go-ahead for use in Africa from October if approved by international regulators. Paul Chapman reports. Video provided by Reuters
Powered by NewsLook.com
3D Food Printing: The Meal of the Future?

3D Food Printing: The Meal of the Future?

AP (Apr. 23, 2015) Developers of 3D food printing hope the culinary technology will revolutionize the way we cook and eat. (April 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins